Inovio Pharmaceuticals
INO
INO
97 hedge funds and large institutions have $48.4M invested in Inovio Pharmaceuticals in 2025 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 21 increasing their positions, 27 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
less funds holding
Funds holding: →
14% less first-time investments, than exits
New positions opened: 24 | Existing positions closed: 28
22% less repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 27
Holders
97
Holding in Top 10
–
Calls
$2.5M
Puts
$111K
Top Buyers
| 1 | +$8.02M | |
| 2 | +$7.63M | |
| 3 | +$5.38M | |
| 4 |
Millennium Management
New York
|
+$3.8M |
| 5 |
D.E. Shaw & Co
New York
|
+$1.89M |
Top Sellers
| 1 | -$4.03M | |
| 2 | -$1.48M | |
| 3 | -$366K | |
| 4 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
-$349K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$234K |
